Anti-TNF alpha antibody [RM1005]
- BOND RX™ Validated
- Recombinant
- Lab Essentials
- 20ul selling size
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(39 Publications)
Anti-TNF alpha antibody [RM1005] (ab307164) is a rabbit recombinant multiclonal antibody detecting TNF alpha in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF, ELISA. Suitable for Human, Mouse, Rat.
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
TNFA, TNFSF2, TNF, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a, Tnfa, Tnfsf2, Tnf, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-TNF alpha antibody [RM1005] (AB307164)
Flow cytometric analysis of 2% paraformaldehyde fixed 0.1% Tween-20 permeabilized Human peripheral blood mononuclear cell (PBMC) treated with 50ng/ml PMA, 200ng/ml Ionomycin calcium and 300ng/ml BFA for 4h (Right) / Untreated control (Left) cells labelling TNF alpha with ab307164 at 1/500 dilution (0.1ug)/ Left and Right (Red) compared with a isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody. Cells were surface stained with anti-CD3 conjugated to Alexa Fluor® 647. Then fixed with 2% PFA for 10min followed by intracellularly stained with ab307164.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-TNF alpha antibody [RM1005] (AB307164)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized Human PBMC (human peripheral blood mononuclear cell) cells labeling TNF alpha with ab307164 at 1/500 (1.12 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 ug/ml) dilution (Green). Confocal image showing increased cytoplasmic staining in human PBMC treated with Phorbol-12-myristate-13-acetate (50ng/ml) and Ionomycin calcium (200ng/ml) and Brefeldin A (300ng/ml) for 4 hours. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (2.5 ug/ml) dilution (Red). The nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 ug/ml) dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-TNF alpha antibody [RM1005] (AB307164)
TNF alpha was immunoprecipitated from 0.35 mg THP-1 (human monocytic leukemia monocyte) treated with 80nM TPA overnight, then treated with 100ng/ml LPS for 3h and add 300ng/ml BFA for another 3h whole cell lysate 5 ug with ab307164 at 1/30 dilution (2ug in 0.18mg lysates). Western blot was performed on the immunoprecipitate using ab307164 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : THP-1 (human monocytic leukemia monocyte) treated with 80nM TPA overnight, then treated with 100ng/ml LPS for 3h and add 300ng/ml BFA for another 3h whole cell lysate 5 ug
Lane 2 : ab307164 IP in THP-1 treated with 80nM TPA overnight, then treated with 100ng/ml LPS for 3h and add 300ng/ml BFA for another 3h whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab307164 in THP-1 treated with 80nM TPA overnight, then treated with 100ng/ml LPS for 3h and add 300ng/ml BFA for another 3h whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 6 seconds
Soluble form (17 kDa) and multimers of soluble form (33 kDa, 51 kDa) were also observed as described in literatures (PMID : 18523283, PMID : 28426652).
All lanes:
Immunoprecipitation - Anti-TNF alpha antibody [RM1005] (ab307164) at 1/1000 dilution
Lane 1:
THP-1 (human monocytic leukemia monocyte) treated with 80nM TPA overnight, then treated with 100ng/ml LPS for 3h and add 300ng/ml BFA for another 3h whole cell lysate 5 μg
Lane 2:
THP-1 treated with 80nM TPA overnight, then treated with 100ng/ml LPS for 3h and add 300ng/ml BFA for another 3h whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 17 kDa,26 kDa,51 kDa
false
Exposure time: 6s
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNF alpha antibody [RM1005] (AB307164)
Immunohistochemical analysis of paraffin-embedded Mouse lung treated w tissue labeling TNF alpha with ab307164 at 1/1000 (0.56 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on mouse lung treated with LPS (1ug/ml for 16 hours) and BFA (1ug/ml for 16h hours) (Image A) and control mouse lung (Image B). The section was incubated with ab307164 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND™ RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNF alpha antibody [RM1005] (AB307164)
Immunohistochemical analysis of paraffin-embedded Mouse cerebrum tissue labeling TNF alpha with ab307164 at 1/1000 (0.56 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Negative control : no staining on mouse cerebrum. The section was incubated with ab307164 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND™ RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNF alpha antibody [RM1005] (AB307164)
Immunohistochemical analysis of formalin fixed paraffin embedded rat lung labelling TNF alpha with ab307164 at a concentration of 1/1000 dilution. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins. The primary antibody Anti-TNF alpha antibody [RM1005] was incubated for 30 mins at room temperature. Sections were counterstained with Hematoxylin.
Positive staining on rat lung treated with LPS (1ug/ml for 16 hours) and BFA (1ug/ml for 16h hours) (Image A) and no staining on wild type rat lung (Image B).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNF alpha antibody [RM1005] (AB307164)
Immunohistochemical analysis of formalin fixed paraffin embedded rat cerebrum labelling TNF alpha with ab307164 at a concentration of 1/1000 dilution. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins. The primary antibody Anti-TNF alpha antibody [RM1005] was incubated for 30 mins at room temperature. Sections were counterstained with Hematoxylin.
Negative control : no staining on rat cerebrum.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-TNF alpha antibody [RM1005] (AB307164)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/ml LPS for 3h and add 1µg/ml BFA for another 3h (Red) / Untreated control (Green) cells labelling TNF alpha with ab307164 at 1/500 dilution (0.1ug) (Red) and Green (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-TNF alpha antibody [RM1005] (AB307164)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized RAW 264.7 (mouse abelson murine leukemia virus-induced tumor macrophage) cells labeling TNF alpha with ab307164 at 1/500 (1.12 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 ug/ml) dilution (Green). Confocal image showing increased cytoplasmic staining in RAW 264.7 treated with lipopolysaccharide (100 ng/ml) and Brefeldin A (1 µg/ml) for 3 hours. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (2.5 ug/ml) dilution (Red). The nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 ug/ml) dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-TNF alpha antibody [RM1005] (AB307164)
TNF alpha was immunoprecipitated from 0.35 mg RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/ml LPS for 4h and add 300ng/ml BFA for another 3h whole cell lysate 10 ug with ab307164 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab307164 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/ml LPS for 4h and add 300ng/ml BFA for another 3h whole cell lysate 10 ug
Lane 2 : ab307164 IP in RAW 264.7 treated with 100ng/ml LPS for 4h and add 300ng/ml BFA for another 3h whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab307164 in RAW 264.7 treated with 100ng/ml LPS for 4h and add 300ng/ml BFA for another 3h whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 6 seconds
Soluble form (17 kDa) and multimers of soluble form (33 kDa, 51 kDa) were also observed as described in literatures (PMID : 18523283, PMID : 28426652).
All lanes:
Immunoprecipitation - Anti-TNF alpha antibody [RM1005] (ab307164) at 1/1000 dilution
Lane 1:
RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/ml LPS for 4h and add 300ng/ml BFA for another 3h whole cell lysate 10 μg
Lane 2:
RAW 264.7 treated with 100ng/ml LPS for 4h and add 300ng/ml BFA for another 3h whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 17 kDa,26 kDa,33 kDa,51 kDa
false
Exposure time: 6s
- WB
Supplier Data
Western blot - Anti-TNF alpha antibody [RM1005] (AB307164)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Soluble form (17 kDa) and multimers of soluble form (33 kDa, 51 kDa) were also observed as described in literatures (PMID : 18523283, PMID : 28426652). Exposure time : 180 seconds
All lanes:
Western blot - Anti-TNF alpha antibody [RM1005] (ab307164) at 1/1000 dilution
Lane 1:
THP-1 (human monocytic leukemia monocyte) whole cell lysate 20 μg
Lane 2:
THP-1 treated with 80nM TPA overnight, then treated with /ml LPS for 3h and add 300ng/ml BFA for another 3h whole cell lysate 20 μg
Lane 3:
RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate 20 μg
Lane 4:
RAW 264.7 treated with /ml LPS for 4h and add 300ng/ml BFA for another 3h whole cell lysate 20 μg
Lane 5:
NR8383 (rat alveolar macrophage) whole cell lysate 20 μg
Lane 6:
NR8383 treated with /ml LPS for 4h and add 300ng/ml BFA for another 3h whole cell lysate 20 μg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 17 kDa,26 kDa,33 kDa,51 kDa
false
Exposure time: 180s
- I-ELISA
Supplier Data
Indirect ELISA - Anti-TNF alpha antibody [RM1005] (AB307164)
Indirect ELISA analysis of ab173305 at 1/1000 ng/ml. The secondary antibody used was Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution. Substrate solution : p-nitrophenyl phosphate(PNPP).
Related conjugates and formulations (1)
-
Anti-TNF alpha antibody [RM1005] - BSA and Azide free
Reactivity data
Product details
Product Specifications
Anti-TNF alpha antibody [RM1005] (ab307164) is a recombinant rabbit multiclonal antibody which is comprised of multiple monoclonal antibodies targeting different epitopes and recapitulating the performance of a polyclonal. Each component clone was developed by Abcam using patented rabbit monoclonal antibody technology.
Anti-TNF alpha antibody [RM1005] (ab307164) is validated for use in ELISA, Flow Cyt (Intra), ICC/IF, IHC-P, IP and WB in human, mouse and rat samples.
Anti-TNF alpha antibody [RM1005] (ab307164) specifically detects TNF alpha/ Tumor necrosis factor alpha (UniProt ID: P06804; Molecular weight: 26kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Quality and Validation
Abcams high quality manufacturing and validation processes ensure Anti-TNF alpha antibody [RM1005] (ab307164)has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Related Products
Conjugation-ready, carrier free format available for antibody clone RM1005 - ab307165.
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
- - The sensitivity of polyclonal antibodies by recognising multiple epitopes
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
View our range of recombinant multiclonal antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (39)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 26: PubMed41009408
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 35:102287 PubMed40989834
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in bioengineering and biotechnology 13:1610806 PubMed40918432
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 34:102234 PubMed40893347
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:29297 PubMed40789880
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 53:366-385 PubMed40727484
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1530655 PubMed40697655
2025
Applications
Unspecified application
Species
Unspecified reactive species
Drug design, development and therapy 19:5871-5898 PubMed40661830
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:6389 PubMed40640139
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 16:1538046 PubMed40547034
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com